242 related articles for article (PubMed ID: 24671677)
1. Engineering HSV-1 vectors for gene therapy.
Goins WF; Huang S; Cohen JB; Glorioso JC
Methods Mol Biol; 2014; 1144():63-79. PubMed ID: 24671677
[TBL] [Abstract][Full Text] [Related]
2. Engineering HSV-1 Vectors for Gene Therapy.
Goins WF; Huang S; Hall B; Marzulli M; Cohen JB; Glorioso JC
Methods Mol Biol; 2020; 2060():73-90. PubMed ID: 31617173
[TBL] [Abstract][Full Text] [Related]
3. Construction and production of recombinant herpes simplex virus vectors.
Goins WF; Krisky DM; Wechuck JB; Huang S; Glorioso JC
Methods Mol Biol; 2008; 433():97-113. PubMed ID: 18679619
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
5. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
6. Generation of replication-competent and -defective HSV vectors.
Goins WF; Krisky DM; Wechuck JB; Wolfe D; Huang S; Glorioso JC
Cold Spring Harb Protoc; 2011 May; 2011(5):pdb.prot5615. PubMed ID: 21536761
[TBL] [Abstract][Full Text] [Related]
7. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
Ishida D; Nawa A; Tanino T; Goshima F; Luo CH; Iwaki M; Kajiyama H; Shibata K; Yamamoto E; Ino K; Tsurumi T; Nishiyama Y; Kikkawa F
Cancer Lett; 2010 Feb; 288(1):17-27. PubMed ID: 19604626
[TBL] [Abstract][Full Text] [Related]
8. Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.
Broberg EK; Peltoniemi J; Nygårdas M; Vahlberg T; Röyttä M; Hukkanen V
J Virol; 2004 Dec; 78(23):13139-52. PubMed ID: 15542666
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery using herpes simplex virus vectors.
Burton EA; Fink DJ; Glorioso JC
DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
[TBL] [Abstract][Full Text] [Related]
10. [Herpes simplex type-1 virus-based vectors for gene therapy].
Ichikawa T; Saeki Y; Tamiya T; Chiocca EA; Ohmoto T
Nihon Rinsho; 2000 Apr; 58(4):822-7. PubMed ID: 10774201
[TBL] [Abstract][Full Text] [Related]
11. HSV-1-derived helper-independent defective vectors, replicating vectors and amplicon vectors, for the treatment of brain diseases.
Marconi P; Manservigi R; Epstein AL
Curr Opin Drug Discov Devel; 2010 Mar; 13(2):169-83. PubMed ID: 20205051
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors.
Melendez ME; Fraefel C; Epstein AL
Methods Mol Biol; 2014; 1144():81-98. PubMed ID: 24671678
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy.
Marconi P; Fraefel C; Epstein AL
Methods Mol Biol; 2015; 1254():269-93. PubMed ID: 25431072
[TBL] [Abstract][Full Text] [Related]
14. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
15. Construction of Oncolytic Herpes Simplex Virus with Therapeutic Genes of Interest.
Kahramanian A; Kuroda T; Wakimoto H
Methods Mol Biol; 2019; 1937():177-188. PubMed ID: 30706396
[TBL] [Abstract][Full Text] [Related]
16. Multiple applications for replication-defective herpes simplex virus vectors.
Burton EA; Wechuck JB; Wendell SK; Goins WF; Fink DJ; Glorioso JC
Stem Cells; 2001; 19(5):358-77. PubMed ID: 11553845
[TBL] [Abstract][Full Text] [Related]
17. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications.
Burton EA; Fink DJ; Glorioso JC
Curr Opin Mol Ther; 2005 Aug; 7(4):326-36. PubMed ID: 16121698
[TBL] [Abstract][Full Text] [Related]
18. Latency associated promoter transgene expression in the central nervous system after stereotaxic delivery of replication-defective HSV-1-based vectors.
Scarpini CG; May J; Lachmann RH; Preston CM; Dunnett SB; Torres EM; Efstathiou S
Gene Ther; 2001 Jul; 8(14):1057-71. PubMed ID: 11526453
[TBL] [Abstract][Full Text] [Related]
19. HSV as a vector in vaccine development and gene therapy.
Marconi P; Argnani R; Berto E; Epstein AL; Manservigi R
Hum Vaccin; 2008; 4(2):91-105. PubMed ID: 18496918
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapy.
Fraefel C; Marconi P; Epstein AL
Methods Mol Biol; 2015; 1254():295-316. PubMed ID: 25431073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]